Figure 5.

G0/G1-phase arrest induced by alpinetin in pancreatic cell lines. BxPC-3, PANC-1, AsPC-1 cells were treated with alpinetin (0, 20, 40, 60 and 80 μg/ml) for 24 h, and then the distribution of cell cycle was determined by flow cytometry. Cell cycle progression in alpinetin-treated three pancreatic cancer cell lines was assessed using flow cytometry. The percentages of G0/G1 phase cell in different groups are shown by columns (^*P<0.05). These results shown represent means ± SD from three independent experiments performed in triplicate.